Katherine Fierlbeck – författare

Despite notable variation in health care policy from province to province, most scholarship published on the health care system in Canada uses a broad national perspective. Focusing on the health care systems of individual Canadian provinces and territories, our new series, Health System Profiles, examines the social, political, economic, and epidemiological context of health care policy in each Canadian province.

Turning a critical eye to the health care system in Nova Scotia, author Katherine Fierlbeck outlines the organizational and regulatory frameworks structuring provincial health care, while providing a detailed assessment of Nova Scotia’s health financing, physical infrastructure, service provision, and the efficacy of technological resources used in data tracking and health quality assessments. Structured for ease of comparison, Nova Scotia: A Health System Profile will, along with other volumes in the series, help scholars draw analytic evidence-based policy conclusions about the health system of Nova Scotia and other Canadian provinces and territories. 

Despite notable variation in health care policy from province to province, most scholarship published on the health care system in Canada uses a broad national perspective. Focusing on the health care systems of individual Canadian provinces and territories, our new series, Health System Profiles, examines the social, political, economic, and epidemiological context of health care policy in each Canadian province.

Turning a critical eye to the health care system in Nova Scotia, author Katherine Fierlbeck outlines the organizational and regulatory frameworks structuring provincial health care, while providing a detailed assessment of Nova Scotia’s health financing, physical infrastructure, service provision, and the efficacy of technological resources used in data tracking and health quality assessments. Structured for ease of comparison, Nova Scotia: A Health System Profile will, along with other volumes in the series, help scholars draw analytic evidence-based policy conclusions about the health system of Nova Scotia and other Canadian provinces and territories.

There is plenty of controversy surrounding pharmaceuticals, but it cannot be denied that the pharmaceutical industry is both socially beneficial and profitable. Regulators are expected to ensure that the economic success of the industry does not come at the expense of public safety, yet they have also assumed a cooperative role by providing advice on regulation and by targeting unmet medical needs. Concerns over regulatory standards, conflicts of interest, and the manipulation of information on drug safety and effectiveness have led to public mistrust and a greater need for transparency between the pharmaceutical industry and government regulators.

Transparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry responsible for creating transparency in the industry, from development to market. The contributors to this volume examine the various mechanisms introduced to make the regulatory process more informative and situate these efforts within the larger project of enhancing the safety of drugs, vaccines, and other products.

There is plenty of controversy surrounding pharmaceuticals, but it cannot be denied that the pharmaceutical industry is both socially beneficial and profitable. Regulators are expected to ensure that the economic success of the industry does not come at the expense of public safety, yet they have also assumed a cooperative role by providing advice on regulation and by targeting unmet medical needs. Concerns over regulatory standards, conflicts of interest, and the manipulation of information on drug safety and effectiveness have led to public mistrust and a greater need for transparency between the pharmaceutical industry and government regulators.

Transparency, Power, and Influence in the Pharmaceutical Industry evaluates the progress made in holding the pharmaceutical industry responsible for creating transparency in the industry, from development to market. The contributors to this volume examine the various mechanisms introduced to make the regulatory process more informative and situate these efforts within the larger project of enhancing the safety of drugs, vaccines, and other products.